29 reports

  • MARKET OUTLINE

You can easily book an appointment with one online.

  • Audio And Video Equipment
  • Dermatology
  • World
  • Olympus Corporation
  • Stryker Corporation
  • DERMATOLOGY PRODUCTS AND R&D PIPELINE - ALLERGAN
  • 10.7 COMPETITIVE ANALYSIS IN ROSACEA MARKET

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Dermatology
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS FOR
  • DERMATOLOGY, GLOBAL, TABLE OF ALL CLINICAL STAGE PIPELINE PRODUCTS, 2016 PART 7

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using Metolate.

  • Dermatology
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Dermatology Therapeutics Market, Global, Overall
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting ORAI1, 2017

It is also in development for various indications in the gastrointestinal, respiratory, and ophthalmology therapy areas.

  • Dermatology
  • World
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.

RISK FACTORS severe acne was related to a higher prevalence of one or more gastrointestinal, sinopulmonary, and psychological co-morbid disorders.

  • Dermatology
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG

RISK FACTORS severe acne was related to a higher prevalence of one or more gastrointestinal, sinopulmonary, and psychological co-morbid disorders.

  • Dermatology
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG

THE COMPANY IS SPECIALIZED IN DERMATOLOGY, EYE HEALTH, GASTROINTESTINAL, NEUROLOGY AND CONSUMER HEALTHCARE.

  • Dermatology
  • Market Size
  • Amgen Inc.
  • Samsung Bioepis Co., Ltd.
  • Sandoz Inc.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using methotrexate.

  • Dermatology
  • World
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.

A study reported that severe acne was related to a higher prevalence of one or more gastrointestinal, sinopulmonary, and psychological co-morbid disorders.

  • Dermatology
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • Research Contact: info@globaldata.com

Besides, one VC deal worth USD##. ##m was reported in Q## 2016.

  • Dermatology
  • Endocrine Disease
  • World
  • Company
  • Deals & Alliance
  • Lee's Pharmaceutical Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018

The drug candidate is a monoclonal antibody that acts on programmed cell death ## ligand-## (PD-L##).

  • Dermatology
  • Ophthalmology
  • Pharmaceutical
  • China
  • CVie
  • Valeant Pharmaceuticals International Inc, Deals By Therapy Area, 2012 to YTD 2018

Interest on the notes is payable semiannually in arrears on June ## and December ## of each year, commencing from December ##, 2012.

  • Dermatology
  • Canada
  • United States
  • M&A
  • Valeant Pharmaceuticals International, Inc.

Wounds - Overview Wounds - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR WOUNDS, H## 2017 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR WOUNDS, H## 2017 Phase III ## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Discovery

  • Dermatology
  • Healthcare
  • Wound Care
  • United States
  • Product Initiative

Key Questions Answered ##.

  • Dermatology
  • Therapy
  • World
  • Market Size
  • Paratek Pharmaceuticals, Inc.

The company intends to use the proceeds to add more data analysis to its products and move into new specialty areas including gastrointestinal care, ENT care and rheumatology.

  • Dermatology
  • Medical Device
  • Patient Data Management
  • United States
  • Modernizing Medicine, Inc.

Additionally, radezolid was well tolerated, with the most commonly reported adverse events being mild gastrointestinal upset.

  • Dermatology
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

Endoscopic data reflect the ability of Brilacidin to help clear Gastrointestinal (GI) tract mucosa in patients suffering from ulcerative colitis.

  • Dermatology
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Mar 02, 2016: Valeant Pharmaceuticals Announces Management Change
  • ASSET TRANSACTIONS

To bring out additional value in our core Branded Rx segment, we dedicated additional resources to enhance our Dermatology and Gastrointestinal (GI) portfolios.

  • Dermatology
  • Pharmaceutical
  • United States
  • M&A
  • Valeant Pharmaceuticals International, Inc.

On July ##, 2016, Mr.

  • Dermatology
  • Ophthalmology
  • Pharmaceutical
  • Refractive Surgery Device
  • GlobalData's company

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Clinical Trial
  • Dermatology
  • Diagnostics
  • United States
  • GlobalData's company

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 155 Trial Title
  • Clinical Trial Profile Snapshots

## ## ## ## ## ## ## Sun Pharmaceutical Industries Ltd ## ## ## ## ## ## ## Smith & Nephew Plc ## ## ## ## ## ## ## Noveome Biotherapeutics Inc ## ## ## ## ## ## ## Mallinckrodt Plc Fibrocell Science Inc CoDa Therapeutics ## ## ## ## ## ## ## ##

  • Dermatology
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • COMPANY OVERVIEW AND KEY FACTS
  • Stock exchange

Salix is a US-based pharmaceutical company focused on treatment of gastrointestinal diseases, while Dr.

  • Dermatology
  • United States
  • Company
  • M&A
  • Valeant Pharmaceuticals International, Inc.

The offering is expected to close on or about April ##, 2008.

  • Dermatology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Oculus Innovative Sciences, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative

Technology and Services Technology and Services--> IT Services ## Darrow Avenue, Suite ## Evanston Illinois United States www. tanvas. co ## ## ## ## ACQUIRER ##: PEAK## INVESTMENTS, L. P.

  • Dermatology
  • Immunology
  • United States
  • Corporate Finance
  • Aptinyx Inc.

The 2018 notes will mature on December ##, 2018. interest on the 2018 notes accrues at a rate of ##. ##% and will be payable semi-annually in arrears on each June ## and December ##, commencing on June ##, 2011.

  • Dermatology
  • United States
  • Company
  • M&A
  • Valeant Pharmaceuticals International, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatological Condition
  • Dermatology
  • Pharmaceutical
  • World

The company focuses on pharmaceutical products in therapeutics, including prescription drugs for gastrointestinal, respiratory, and cardiovascular indications, as well as on OTC medication.

  • Dermatology
  • Pharmaceutical
  • United States
  • M&A
  • Peplin, Inc.